May 14, 2020 / 9:05 PM / 17 days ago

BRIEF-Armata Pharma Reports Quarterly Loss Per Share Of $0.49

May 14 (Reuters) - Armata Pharmaceuticals Inc:

* ARMATA PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 RESULTS AND PROVIDES GENERAL CORPORATE UPDATE

* ARMATA PHARMACEUTICALS INC - WELL CAPITALIZED WITH $24.2 MILLION OF UNRESTRICTED CASH AND CASH EQUIVALENTS AS OF MARCH 31

* ARMATA PHARMACEUTICALS INC QTRLY LOSS FROM OPERATIONS WAS $4.9 MILLION AS COMPARED TO $3.4 MILLION

* ARMATA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.49 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below